Latest Announcements

Torrent Pharmaceuticals Limited successfully held its 53rd Annual General Meeting on June 23, 2026, and announced that all resolutions were duly approved by shareholders. Key resolutions passed included the adoption of standalone and consolidated financial statements for FY2026, confirmation of interim dividend and declaration of final dividend, re-appointment of Director Samir Mehta, and ratification of cost auditor remuneration. Significantly, shareholders also approved a special resolution for the issuance of equity shares including convertible bonds/debentures, enabling future capital raising activities.

Torrent Pharmaceuticals Ltd announced the declaration of voting results for its 53rd Annual General Meeting held on June 23, 2026. All resolutions proposed were duly approved by shareholders with requisite majority. Key approvals include the adoption of standalone and consolidated financial statements for FY26, confirmation of interim and declaration of final dividend, re-appointment of Samir Mehta as Director, and the crucial approval for the issuance of equity shares including convertible bonds/debentures, which passed with 99.93% votes in favor.

Torrent Pharmaceuticals Ltd held its 53rd Annual General Meeting on June 23, 2026, where shareholders approved the Standalone and Consolidated Financial Statements for the fiscal year ended March 31, 2026. The meeting confirmed an interim dividend of ₹29.00 and declared a final dividend of ₹9.00 per equity share for FY26. Significantly, shareholders also approved the issuance of equity shares, including convertible bonds/debentures, providing the company with flexibility for future fundraising. Additionally, Samir Mehta was re-appointed as Director, and the remuneration of cost auditors for 2026-27 was ratified.

Torrent Pharmaceuticals Limited's 53rd Annual General Meeting (AGM) on June 23, 2026, approved standalone and consolidated financial statements for FY26. Shareholders confirmed an interim dividend of ₹29.00 and declared a final dividend of ₹9.00 per equity share for FY26. Key resolutions also included the re-appointment of Director Samir Mehta, ratification of cost auditor remuneration, and the approval for the issuance of equity shares including convertible bonds/debentures, signaling potential future capital raising.

Super Crop Safe Ltd has allotted 1,17,44,722 equity shares at INR 13 each on a preferential basis to two non-promoter entities, Wherrelz IT Solutions Limited and Voltrix INC. This allotment, totaling approximately INR 15.27 crores, is for the conversion of outstanding unsecured loans into equity, which strengthens the company's balance sheet by reducing debt. Following this issuance, the company's paid-up equity share capital increased, and the promoter group's shareholding diluted from 32.36% to 25.05%.

Satin Creditcare Network Limited's board approved a proposal to raise up to INR 5,000 Crore through Non-Convertible Debentures (NCDs) via private placement, subject to shareholder approval at the upcoming Annual General Meeting (AGM). The board also re-appointed Mr. Vikas Gupta as Chief Compliance Officer for a further three-year term, effective July 11, 2026. The company's 36th AGM is scheduled for August 7, 2026.

Satin Creditcare Network Ltd's Board has approved a proposal to raise up to INR 5,000 Crore through Non-Convertible Debentures (NCDs) via private placement, subject to shareholder approval in the upcoming Annual General Meeting. This significant fundraise is expected to support the company's operational needs and growth initiatives. Additionally, Mr. Vikas Gupta has been re-appointed as the Chief Compliance Officer for a further three-year term, and the 36th AGM is scheduled for August 7, 2026.

Muthoot Microfin Ltd has scheduled a Board Meeting for June 30, 2026, to primarily consider and approve the authorization for issuing Non-Convertible Debentures (NCDs) aggregating up to INR 40,000 crores. This includes INR 30,000 crores via private placement and INR 10,000 crores through public issue during the financial year 2026-27. Additionally, the board will discuss the scheduling of the company's Annual General Meeting.

Power Finance Corporation (PFC) has successfully priced and launched a USD 300 million bond issue with a 5.32% coupon rate, maturing in 2031. These notes, part of a larger Global Medium Term Note Programme, will be listed on NSE IFSC and India INX. The proceeds from this fundraise are earmarked for use in accordance with the Reserve Bank of India's external commercial borrowing guidelines, bolstering PFC's financial capacity for its lending operations.

Power Finance Corporation Ltd (PFC) has successfully priced an issuance of U.S. $300 million 5.32% notes due 2031 under its Global Medium Term Note Programme. Priced on June 22, 2026, with settlement expected by June 30, 2026, the notes carry a 5.32% annual coupon payable semi-annually. The net proceeds will be utilized in accordance with RBI's external commercial borrowing guidelines, and the notes will be listed on NSE IFSC and India INX.

Kalyani Cast-Tech Ltd has scheduled a Board of Directors meeting on June 30, 2026, to consider and approve the issuance of equity shares and/or convertible securities, including warrants, on a preferential basis under SEBI (ICDR) Regulations, 2018. The board will also determine the issue price, subject to regulatory approvals and shareholder consent. The trading window for designated persons has been closed from June 23, 2026, until 48 hours after the board meeting's outcome is made public.

Embassy Office Parks REIT has successfully allotted 70,000 Series XVII Non-Convertible Debentures (NCDs) aggregating to ₹700 Crores through a private placement. These secured, redeemable NCDs have a 3-year tenure with a coupon rate of 7.49% per annum, payable quarterly. The issue price was discovered via electronic book building on BSE Limited, yielding slightly over the principal amount. These NCDs are proposed to be listed on the Wholesale Debt Market Segment of BSE Limited, providing the REIT with significant capital.

Aelea Commodities Ltd has announced the enhancement of its credit facility by ₹13.86 Crores from HDFC Bank Ltd. This working capital term loan is availed under the Emergency Credit Line Guaranteed Scheme (ECLGS) 5.0, a government-backed initiative for eligible borrowers. The facility was sanctioned on June 23, 2026, and involves a second-ranking charge over existing and new assets, aimed at supporting the company's operational needs and strengthening its liquidity.

Mizzen Ventures Ltd will hold an Extra Ordinary General Meeting on July 15, 2026. The key agenda items include increasing the company's Authorized Share Capital from INR 22.10 crores to INR 22.80 crores, and approving a preferential issue of equity shares to non-promoters for cash consideration. This move indicates the company's intent to raise capital to fund future operations or expansion plans.

Aelea Commodities Ltd's Board of Directors approved the enhancement of credit facilities totaling Rs. 13.86 crore. This additional working capital term loan facility is being availed from HDFC Bank Ltd under the Emergency Credit Line Guarantee Scheme (ECLGS) 5.0, a government-backed scheme. The company is deemed an eligible borrower under the scheme guidelines.

Yash Highvoltage Ltd has announced an Extra-Ordinary General Meeting (EOGM) scheduled for July 15, 2026. The primary agenda for this EOGM is to seek shareholder approval for a preferential issue of equity shares and warrants. The company proposes to offer and issue up to 1,262,131 equity shares of ₹5 each and 832,177 equity warrants on a preferential basis to certain non-promoter persons, aimed at strengthening its capital base.

Krishna Institute of Medical Sciences Limited has received approval from both BSE and NSE for the listing of 1,98,67,549 equity shares. These shares, with a face value of Rs. 2/- each, were issued to qualified institutional buyers through a Qualified Institutional Placement (QIP). This intimation confirms the successful completion of the regulatory process for the QIP shares to be traded on the exchanges.

Krishna Institute of Medical Sciences Ltd has received approval from both the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE) for the listing of 1,98,67,549 new equity shares. These shares, each with a face value of Rs. 2/-, were issued to qualified institutional buyers through a qualified institutional placement (QIP). This intimation confirms the final procedural step for the shares to be traded on the exchanges following the successful completion of the QIP.

Viceroy Hotels Limited has announced a Board Meeting on June 29, 2026, to consider and approve raising funds through a rights issue of equity shares to existing shareholders. This fundraise will adhere to the Companies Act and SEBI ICDR Regulations. Concurrently, the trading window for Designated Persons and their immediate relatives is closed from the date of the announcement until 48 hours after the Board Meeting.

Viceroy Hotels Ltd announced a Board Meeting on June 29, 2026, to consider and approve raising funds through a rights issue of equity shares to its existing shareholders. This fundraise aims to support the company's financial requirements and growth plans. In compliance with insider trading regulations, the trading window for designated persons and their immediate relatives has been closed until 48 hours after the conclusion of the board meeting.